Survey of the nutritional status of patients with a tumor in the oral cavity, pharynx, nasal cavity, middle ear, paranasal sinus and larynx at initial presentation to the Department of Nutritional Medicine at Münster University Hospital

Conditions: C00-C14
C30
C31
C32
Malignant neoplasms of lip, oral cavity and pharynx
Malignant neoplasm of nasal cavity and middle ear
Malignant neoplasm of accessory sinuses
Malignant neoplasm of larynx

Registration Number: DRKS00023259

Lead Sponsor: niversitätsklinikum Münster, Medizinische Klinik B Gastroenterologie, Hepatologie, Endokrinologie, Klinische Infektiologie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 50

Inclusion Criteria

Initial presentation to the Department of Nutritional Medicine at Münster University Hospital of patients with a tumor of the oral cavity and pharynx [ICD-10 C00-C14], nasal cavity and middle ear [ICD-10 C30], paranasal sinus [ICD-10 C31], and larynx [ICD-10 C32](ENT tumor).

First diagnosis of ENT tumor within the past 3 months

=/> 18 years

of any sex

outpatient or inpatient (consultative access) care setting of the Department of Nutritional Medicine of Münster University Hospital

Exclusion Criteria

Patients in whom BIA cannot be performed due to physical constitution:
- pacemaker
- defibrillator
- amputations
- severe skin diseases (e.g. pronounced psoriasis or extensive wounds of the extremities)

implausible BIA raw data (e.g. hydration status)

pregnant or breastfeeding women

missing or insufficient German or English language skills

Lack of ability to give consent

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Phase angle (°), Body Cell Mass (BCM) (kg), ECM/BCM-Index (ECM: extracellular mass), cell amount (%), weight (kg), height (m), BMI (kg/m2)

Secondary Outcome Measures

Name	Time	Method
age (years), gender (m/w), Nutritional Risk Screening (NRS) 2002 (NRS-score), regular use (3x/week) of nutritional, high-calorie Supplements within the last 7 days